Dupont Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-84,550
| Closed | -$5.31M | – | 54 |
|
|
2026
Q1 | $5.31M | Sell |
84,550
-8,869
| -9% | -$709K | 0.6% | 56 |
|
|
2025
Q4 | $8.91M | Sell |
93,419
-11,579
| -11% | -$1.14M | 1% | 42 |
|
|
2025
Q3 | $10.3M | Sell |
104,998
-9,946
| -9% | -$1.03M | 1.06% | 35 |
|
|
2025
Q2 | $12.3M | Hold |
114,944
| – | – | 1.33% | 23 |
|
|
2025
Q1 | $11.6M | Sell |
114,944
-28,493
| -20% | -$2.87M | 1.28% | 26 |
|
|
2024
Q4 | $12.8M | Hold |
143,437
| – | – | 1.19% | 24 |
|
|
2024
Q3 | $12M | Sell |
143,437
-25,373
| -15% | -$2M | 1% | 28 |
|
|
2024
Q2 | $13M | Sell |
168,810
-32,265
| -16% | -$2.36M | 1.13% | 20 |
|
|
2024
Q1 | $13.8M | Sell |
201,075
-32,095
| -14% | -$2.06M | 1.14% | 23 |
|
|
2023
Q4 | $13.5M | Sell |
233,170
-77,941
| -25% | -$4.16M | 1.18% | 24 |
|
|
2023
Q3 | $16.4M | Buy |
311,111
+178,488
| +135% | +$9.36M | 1.43% | 16 |
|
|
2023
Q2 | $7.17M | Buy |
132,623
+20,705
| +19% | +$1.08M | 0.35% | 57 |
|
|
2023
Q1 | $5.6M | Buy |
111,918
+23,065
| +26% | +$1.09M | 0.27% | 60 |
|
|
2022
Q4 | $4.11M | Buy |
88,853
+18,426
| +26% | +$798K | 0.19% | 69 |
|
|
2022
Q3 | $2.73M | Sell |
70,427
-50,518
| -42% | -$2.03M | 0.16% | 113 |
|
|
2022
Q2 | $4.51M | Sell |
120,945
-19,401
| -14% | -$790K | 0.21% | 72 |
|
|
2022
Q1 | $6.22M | Sell |
140,346
-11,843
| -8% | -$513K | 0.25% | 62 |
|
|
2021
Q4 | $6.46M | Sell |
152,189
-41,094
| -21% | -$1.73M | 0.23% | 74 |
|
|
2021
Q3 | $8.39M | Sell |
193,283
-54,736
| -22% | -$2.42M | 0.26% | 60 |
|
|
2021
Q2 | $10.6M | Buy |
248,019
+77,878
| +46% | +$3.28M | 0.25% | 70 |
|
|
2021
Q1 | $6.58M | Sell |
170,141
-46,948
| -22% | -$1.78M | 0.16% | 101 |
|
|
2020
Q4 | $7.8M | Sell |
217,089
-9,059
| -4% | -$327K | 0.17% | 103 |
|
|
2020
Q3 | $8.64M | Sell |
226,148
-15,104
| -6% | -$582K | 0.19% | 100 |
|
|
2020
Q2 | $8.47M | Buy |
241,252
+168,516
| +232% | +$6.07M | 0.19% | 102 |
|
|
2020
Q1 | $2.37M | Buy |
72,736
+1,666
| +2% | +$65.1K | 0.06% | 253 |
|
|
2019
Q4 | $3.21M | Sell |
71,070
-16,392
| -19% | -$686K | 0.07% | 230 |
|
|
2019
Q3 | $3.56M | Buy |
87,462
+10,926
| +14% | +$463K | 0.08% | 213 |
|
|
2019
Q2 | $3.29M | Sell |
76,536
-57,829
| -43% | -$2.22M | 0.08% | 251 |
|
|
2019
Q1 | $5.16M | Sell |
134,365
-18,580
| -12% | -$710K | 0.12% | 159 |
|
|
2018
Q4 | $5.41M | Buy |
152,945
+808
| +0.5% | +$29.3K | 0.13% | 142 |
|
|
2018
Q3 | $5.86M | Sell |
152,137
-15,175
| -9% | -$530K | 0.13% | 139 |
|
|
2018
Q2 | $5.47M | Buy |
167,312
+3,604
| +2% | +$109K | 0.13% | 143 |
|
|
2018
Q1 | $4.47M | Buy |
163,708
+144,196
| +739% | +$3.92M | 0.11% | 186 |
|
|
2017
Q4 | $484K | Buy |
19,512
+10,714
| +122% | +$296K | 0.01% | 661 |
|
|
2017
Q3 | $257K | Buy |
+8,798
| New | +$243K | 0.01% | 783 |
|
|
2016
Q4 | – | Sell |
-231,533
| Closed | -$5.51M | – | 815 |
|
|
2016
Q3 | $5.51M | Buy |
+231,533
| New | +$5.52M | 0.12% | 162 |
|
|
2015
Q2 | – | Sell |
-118,000
| Closed | -$2.1M | – | 568 |
|
|
2015
Q1 | $2.1M | Sell |
118,000
-185,600
| -61% | -$2.93M | 0.04% | 360 |
|
|
2014
Q4 | $4.02M | Sell |
303,600
-27,900
| -8% | -$357K | 0.07% | 223 |
|
|
2014
Q3 | $3.92M | Buy |
331,500
+15,700
| +5% | +$198K | 0.07% | 235 |
|
|
2014
Q2 | $4.03M | Buy |
+315,800
| New | +$4.11M | 0.07% | 250 |
|
|
2014
Q1 | – | Sell |
-341,326
| Closed | -$4.1M | – | 628 |
|
|
2013
Q4 | $4.1M | Sell |
341,326
-69,897
| -17% | -$826K | 0.07% | 226 |
|
|
2013
Q3 | $4.83M | Buy |
411,223
+14,250
| +4% | +$154K | 0.09% | 208 |
|
|
2013
Q2 | $3.68M | Buy |
+396,973
| New | +$3.37M | 0.07% | 252 |
|
Other funds holding BSX
Dupont Capital Management's BSX Position: Q2 2026 in Review
Dupont Capital Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 84,550 shares — an estimated $5.31M sold.
Dupont Capital Management first reported a position in BSX in Q2 2013 and held it in 43 quarters. The position peaked at $16.4M in Q3 2023. 1,473 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Dupont Capital Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
- Dupont Capital Management sold 84,550 Boston Scientific shares in Q2 2026, an estimated $5.31M.
- Dupont Capital Management first reported a position in Boston Scientific in Q2 2013 and held it in 43 quarters.
- Dupont Capital Management's Boston Scientific position peaked at $16.4M in Q3 2023.
- 1,473 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Dupont Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.